Medicine in Omics

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Medicine in Omics is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,230 USD. Declared review time at DOAJ: 38 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2590-1249
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
2,230 USD
Articles in DOAJ
26
Declared review time
38 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2024-03-25
Indexing
DOAJ
APC
2,230 USD
Declared review time (DOAJ)
38 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

26

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

38weeks

Works in OpenAlex

57

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

8

i10-index

7

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-04-27
Added to DOAJ
2024-03-25
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
39%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification4

Subjects (DOAJ)

MedicineScience: Biology (General): Genetics

LCC codes

RQH426-470

Subject areas

  • RNA modifications and cancer
  • RNA modifications and cancer
  • vaccines and immunoinformatics approaches
  • vaccines and immunoinformatics approaches
  • Computational Drug Discovery Methods
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Computational Drug Discovery Methods
Show all subjects (50)
  • SARS-CoV-2 and COVID-19 Research
  • Liver Disease Diagnosis and Treatment
  • Bioinformatics and Genomic Networks
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Tuberculosis Research and Epidemiology
  • Liver Disease Diagnosis and Treatment
  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Bioinformatics and Genomic Networks
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Gut microbiota and health
  • Gut microbiota and health
  • Peptidase Inhibition and Analysis
  • Radiomics and Machine Learning in Medical Imaging
  • Viral Infections and Outbreaks Research
  • Monoclonal and Polyclonal Antibodies Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • COVID-19 Clinical Research Studies
  • Microbial Metabolism and Applications
  • RNA and protein synthesis mechanisms
  • RNA Research and Splicing
  • Gene expression and cancer classification
  • Single-cell and spatial transcriptomics
  • Bioactive Natural Diterpenoids Research
  • Microbial Metabolism and Applications
  • AI in cancer detection
  • Antimicrobial Peptides and Activities
  • Radiomics and Machine Learning in Medical Imaging
  • Monoclonal and Polyclonal Antibodies Research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • COVID-19 Clinical Research Studies
  • Peptidase Inhibition and Analysis
  • Viral Infections and Outbreaks Research
  • Bioactive Natural Diterpenoids Research
  • Single-cell and spatial transcriptomics
  • Gene expression and cancer classification
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • AI in cancer detection
  • Antimicrobial Peptides and Activities

Keywords (DOAJ)

  • genomics
  • proteomics
  • epigenomics
  • metabolomics
  • lipidomics
  • microbiomics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: